Skip to Content

Nostetta made an investment in biopharmaceutical company Aurealis Pharma

Nostetta has invested in a privately owned biopharmaceutical company Aurealis Pharma. The company based in Kuopio, Finland and Basel, Switzerland, has developed an effective, safe and economical treatment method that greatly improves the quality of life for chronic inflammation and cancer sufferers.

Nostetta invested in OwnSurround, a developer of 3D sound technology for headphones

We are happy to announce our newest addition to Nostetta portfolio: OwnSurround, a company developing technology that brings personally tailored 3D surround sound to the user’s own headphones. The technology can be utilized for example in adding real multi-channel sound to video game or movie experience.

VRT Finland accepted into Tekes NIY-program

We are happy to announce that Nostetta’s portfolio company VRT Finland Oy has been accepted into Tekes NIY-program, which is intended to fund and support international growth of young and innovative companies with high global business potential. Congrats VRT!

Nostetta has a new look

Where there’s growth, there’s change. This applies also to Nostetta, so we decided to update our visuals to match the new state of the company. We think it’s a match. Do you?

looks2

Nostetta portfolio grows with addition of VRT Finland

Nostetta has invested in VRT Finland, a tech startup specializing in underwater inspections with the latest 3D-measurement technology. VRT’s solutions ensure that damages or changes in structures do not cause surprises, saving the customer time and money. Welcome aboard VRT!